No Data
US Stock MarketDetailed Quotes
MRNS Marinus Pharmaceuticals
Watchlist
7.390
+0.170+2.35% Close 06/02 16:00 ET
7.3900.0000.00%
Post 16:01 ET
7.520High7.145Low633.73KVolume
7.330Open7.220Pre Close4.64MTurnover1.73%Turnover RatioLossP/E (TTM)373.55MMarket Cap9.82052wk HighLossP/E (Static)50.55MShares3.46552wk Low4.61P/B271.14MFloat Cap82.880Historical High--Dividend TTM36.69MShs Float3.080Historical Low--Div YieldTTM5.19%Amplitude7.319Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Company
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.
Revenue Breakdown
Business
Unit:USD
NameYOYOperating income%
Single Segment--25.48M100.00%
News
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
RADNOR, Pa.--(BUSINESS WIRE)--$MRNS #MarinusPharma--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure diso
Marinus Pharma Option Alert: Jan 19 $8 Calls Sweep (3) Near the Ask: 714 @ $1.844 Vs 0 OI; Ref=$7.255
Marinus Pharma Option Alert: Jan 19 $8 Calls Sweep (3) near the Ask: 714 @ $1.844 vs 0 OI; Ref=$7.255
Express News | Marinus Pharmaceuticals Price Target Maintained With a $18.00/Share by JMP Securities
Comments
ColumnsToday's Pre-Market Stock Movers: ACN, CRM, LEN, NVAX and More
Gapping up
In reaction to earnings/guidance:
• $Deutsche Bank(DB.US$ +5.6%,$Salesforce(CRM.US$ +2.3%,$H.B. Fuller(FUL.US$ +2.2%,$Trip.com(TCOM.US$ +0.7%
Other news:
• $Precigen(PGEN.US$ +3.9% (names new COO)
• $Scorpio Tankers(STNG.US$ +2.7% (reports it purchased its common shares in the open market and exercised a purchase option for an LR2 product tanker that is currently leased)
• $Marinus Pharmaceuticals(MRNS.US$ +1.6% (...
In reaction to earnings/guidance:
• $Deutsche Bank(DB.US$ +5.6%,$Salesforce(CRM.US$ +2.3%,$H.B. Fuller(FUL.US$ +2.2%,$Trip.com(TCOM.US$ +0.7%
Other news:
• $Precigen(PGEN.US$ +3.9% (names new COO)
• $Scorpio Tankers(STNG.US$ +2.7% (reports it purchased its common shares in the open market and exercised a purchase option for an LR2 product tanker that is currently leased)
• $Marinus Pharmaceuticals(MRNS.US$ +1.6% (...
10
1
ColumnsToday's pre-market stock movers: TSLA, JPM, NVAX, CAG and more
Gainers:
• $Theravance Biopharma(TBPH.US$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma(AMYT.US$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners(GRBK.US$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy(TGA.US$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
• $Theravance Biopharma(TBPH.US$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma(AMYT.US$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners(GRBK.US$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy(TGA.US$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
10
1
5
Read more